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A new quantum dot (QD) PEGylated micelle laced with phosphatidylserine (PS) for specific scavenger receptor-mediated
uptake by macrophages is reported. The size and surface chemistry of PS-QD micelles were characterized by
standard methods and the effects of their physicochemical properties on specific targeting and uptake were
comprehensively studied in a monocytic cell line (J774A.1).
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Macrophage plays an important role in the destabili-
zation of atherosclerotic lesions. Molecular imaging ap-
proaches that target and image macrophages may be
potentially useful towards predicting plaque vulnerability
during the natural history of the disease [1-5]. Macro-
phages are effective efferocytes with the ability to re-
cognize the externalized phosphatidylserine (PS) on the
plasma membrane surface of apoptotic cells via the sca-
venger receptors and remove them from circulation and
the arterial wall [6-9]. Phosphatidylserine is a naturally
occurring phospholipid (PL) and its use for targeting
macrophages may improve the biocompatibility of the
contrast agent and avoid the use of exogenous targeting
agents such as antibodies and peptides. This approach of
using phosphatidylserine for targeting macrophages has
been reported previously for magnetic resonance imaging
of macrophage contents in atheroma with gadolinium-
containing liposomes [10] but PS-containing micelles have
not been reported. Lipid-polyethylene glycol (PEG) mi-
celles have traditionally been used to solubilize hydropho-
bic drugs and solubilize hydrophobic nanoparticles into
discrete clusters that can include either single or multiple* Correspondence: bagalkot.vaishali@gmail.com
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reproduction in any medium, provided the orignanoparticles in their cores and thus can achieve size tun-
ability for particular application [11]. Micelles formed
from lipid-PEG are biocompatible, non-toxic, and stable
in vivo [11-16]. For the purpose of tracking the uptake of
micelles by macrophages, QDs were incorporated into the
micelle preparations because of its extreme brightness and
photostability in real time imaging. Furthermore, QDs can
be substituted by other inorganic nanoparticles such as
gadolinium, iron oxide, gold, and tantalum for clinical
translation. The PS micelles were further assembled with
an amphiphilic polymeric surfactant, phospholipid con-
jugated to polyethylene glycol (PL-PEG) for the solu-
bilization of hydrophobic nanoparticles (QD), improved
dispersibility of micelles in physiological buffers and pro-
longed circulation in vivo [14]. However, PEGylation can
potentially interfere with the interactions between ligand
and cell surface receptor and reduce cellular uptake
[17,18], a fine balance between stability and targeting
for PEGylated nanoparticles were extensively studied.
We hypothesize that the ratio of PL-PEG and PS shell
coverage for 6- to 8-nm hydrophobic trioctylphosphine
oxide (TOPO) quantum dot (QD) could be optimized for
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USA). All other chemicals were obtained from Sigma-
Aldrich Corporation (St. Louis, MO, USA). Dulbecco's
modified Eagle's medium (DMEM), fetal bovine se-
rum (FBS), phosphate-buffered saline (PBS), penicillin-
streptomycin, and hydrophobic trioctylphosphine oxide
(TOPO) QDs (QD 620nm) were purchased from Ocean
Nanotech, Corp (Carlsbad, CA, USA). MTT assay kit was
purchased from Roche Applied Science (Indianapolis, IN,
USA). Lab-TekTM chamber slide system was purchased
from Thermo Scientific/Nalgene Nunc International
(Rochester, NY, USA). Vectashield mounting medium
with DAPI was purchased from Vector Laboratories,
Inc. (Burlingame, CA, USA). J774A.1 monocytic cell
line was obtained from American Type Cell line Col-
lection (ATCC) (ATCC® TIB67™). A 100-kD dialysis
membrane was purchased from Spectrum Laboratories
(Irvine, CA, USA).
Preparation of PS-QD micelles
Micelles were prepared by the addition of hydrophobic
QDs in chloroform to phospholipids (PLs) at each mole
ratio (PEG/PS 100:0, 60:40, 50:50, 40:60, and 0:100) in
hot water under vigorous stirring, followed by high-speed
homogenization to form a uniform milky micro-emulsion.
Unless otherwise mentioned, only PS mole ratio is shown
and the remaining assumed for PL-PEG mole ratio (for
example, PS (0) means micelles made entirely from phos-
pholipid methoxy PEG, PS (40) means PS/PL-PEG mole
ratio is 60:40). Briefly, the PLs at various mole ratios as in-
dicated in Table 1 were first dissolved in water at 50°C
and QD 620 (0.2 nmol) dissolved in chloroform was added
to PLs in water and briefly sonicated for a few minutes.
Next, the emulsion of lipids and QDs were thoroughly
mixed by a high-speed homogenizer and maintained in a
hot water bath at 70°C under vigorous stirring inside a
hood to evaporate the chloroform solvent, resulting in theTable 1 Preparation and physico-chemical characteristics of P
Polar lipids
(mg)




QD-PEG-PS mole ratio DSPE-PEG
(2000) methoxy
100:0, PS (0) 4.5 - 0.2 nmol
60:40, PS (40) 2.7 1.8 0.2 nmol
50:50, PS (50) 2.25 2.25 0.2 nmol
40:60, PS (60) 1.8 2.7 0.2 nmol
0:100, PS (100) - 4.5 0.2 nmol
QD-PEG-COOH DSPE-PEG (2000)
carboxylic acid
4.5 - 0.2 nmolsolubilization of hydrophobic QDs in water. The obtained
PS-QD micellar suspension was further purified to re-
move excess PLs by overnight dialysis against phos-
phate buffer (PBS) saline using a 100-kD dialysis cutoff
membrane.
Physico-chemical characterization of PS-QD micelles
The mean hydrodynamic diameter, polydispersity index
and zeta potential charge of PS-QD micelles was mea-
sured using a Zeta Nanosizer ZS (Malvern Instruments
Ltd, Worcestershire, UK; Table 1). For size measurements,
the PS-QD micelles were diluted (1:100) in 100-mM PBS
buffer and for zeta potential measurements the PS-QD
micelles were diluted (1:1,000) in 10-mM PBS buffer. All
samples were measured in triplicate. The morphology of
PS-QD micelles was analyzed by transmission electron
microscopy (TEM; JEM1010; JEOL, Tokyo, Japan) opera-
ting at 60kV. For the preparation of PS-QD micelles for
TEM, PS-QD micelles were diluted in distilled water and
dropped on Formvar-coated copper grids. Samples were
examined with and without negatively staining with os-
mium tetroxide.
In vitro stability of PS-QD micelles
The colloidal stability of PS-QD micelles was analyzed
by incubating PS-QD micelles in cell culture medium
containing 10% fetal bovine serum (FBS). Four-hundred
microliters of PS-QD micelles (QD concentration 1 μM)
were diluted in 800 μL of cell culture media and placed in
a 37°C water bath for 24 h. After 24 h, 0.5 mL of the mi-
celle solution in media was diluted twice with PBS buffer
(0.1M) for particle size analysis using a Zeta Nanosizer ZS.
In vitro cell uptake (fluorescence microscopy and flow
cytometry studies)
The cellular uptake and distribution of PS-QD micelles















Clear Stable 104.6 0.18 −16.4
Clear Stable 40.9 0.14 −14.5
Hazy Stable 143.0 0.16 −21.8
Hazy Stable 127.3 0.22 −32.2
Clear Stable 60.1 0.22 −25.3
Figure 1 Physico-chemical characterization of PS-QD micelles
by dynamic light scattering. The mean hydrodynamic diameters
of micelles with varying PL-PEG/PS mole ratio. PS (0, 40, 50, 60, 100)
micelles were 198.3 ± 3.7, 104.6 ± 9.7, 40.9 ± 0.5, 133.6 ± 17.9, and
127.3 ± 23.3 nm, respectively. The zeta potential values were −14.5 ±
7.5mV for PS (50) micelles, −16.4 ± 6.9mV for PS (60) micelles, to −32.5 ±
7.8mV for PS (100) micelles, respectively.
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confluency, the cells were detached by a scraper and
seeded onto a 6-well plate at a density of 2 × 104 cells
per well and incubated overnight. The culture me-
dium was removed and PS-QD micelles PS (0), (40),
(50), (60), and (100) at 10-nM concentration were
added and incubated for 4h at 37°C. After incubation,
the solution was removed and the cells were washed
with PBS for at least three times. After washing with
PBS, cells were scraped and centrifuged, the super-
natant was carefully removed. PBS buffer containing
2% (v/v) FBS was added to the cell pellet and resus-
pended. The cells were analyzed using a FACS Calibur
fluorescence-activated cell sorter (FACS™) equipped with
Cell Quest software (Becton Dickinson Biosciences, San
Jose, CA, USA). For flourescence microscopy, J774A.1
cells were seeded onto 4-well chamber slides at a density
of 4.0 × 103 per well (surface area of 1.7cm2 per well,
4-chamber slides) and incubated for 24h at 37°C. The
PS-QD micelles PS (0), (40), (50), (60), and (100) at
10-nM concentration were added to the cells and in-
cubated for 4h at 37°C. After incubation, the solution
was removed and the cells were washed with PBS for
at least three times. The cells were fixed with 4% for-
malin for 10min and washed with PBS and mounted
with the DAPI mounting medium for nuclear stain-
ing. The cells were examined by an epifluorescence
microscope (NIKON Eclipse) using separate filters for
nuclei, DAPI filter (blue), and for QD (620); TRITC
filter (red).
Cell cytotoxicity
J774A.1 macrophage cells were cultured with DMEM
supplemented with 10% FBS, 100 U/mL penicillin, and
100μg/mL streptomycin in a 5% CO2 atmosphere at
37°C. The cytotoxicity of PS-QD micelles on J774A.1
cells was evaluated using a colorimetric MTT assay
kit. After the cells achieved 80% confluency, the cells
were scraped and seeded onto a 96-well plate at a
density of 1.5 × 104 cells per well. After 24h of incuba-
tion, the cell culture medium was removed. All PS-QD
micelles were filtered using a 0.45-μM syringe filter be-
fore addition to the cell culture medium. PS-QD mi-
celles PS (0), (40), (50), (60), and (100) at concentrations
of 1-, 5-, 10-, and 50-nM concentrations were incubated
with the cells for 24 h at 37°C under a 5% CO2 atmos-
phere. After incubation, the medium was removed and
the cells were washed with PBS three times. Fresh me-
dium was added to the wells with 10 μL of MTT re-
agent at 37°C for 4 h according to the manufacturer's
protocol. The absorbance was read at a wavelength of
550 nm with a spectramax microplate reader (Molecular
Devices, Sunnyvale, CA, USA). The assay was run in
triplicates.Results and discussion
The molecular self assembly of QDs and PLs was ac-
complished by the addition of hydrophobic QDs to PLs
in an organic solvent in hot water under vigorous stir-
ring, followed by high-speed homogenization to form a
uniform milky micro-emulsion. After the evaporation
of the organic solvent at 40°C to 60°C for about 10
min, micellar PS-QD nanoparticles are formed (Table 1,
Additional file 1: Figure S1). The micellar PS-QD nano-
particles were characterized by dynamic light scattering
(DLS) and zeta potential measurements (Table 1). Unless
otherwise mentioned, all mole ratios represent the molar
ratio of PS/PL-PEG (methoxy) and only PS is denoted for
clarity. The size distribution of QD-micelles formed en-
tirely with PL-PEG (PS (0)) were 198.3 ± 3.7 nm (Figure 1,
Additional file 1: Figure S3). Up to 50 mol% occupancy of
PEG, the results are consistent with prior reports demon-
strating the linear relationship between the hydrodynamic
diameter of nanoparticles and PEG density [19]. However,
with further decrease in PL-PEG, the size of PS micelles
increased. The mean hydrodynamic diameter of PS (60)
micelles was 133.6 ± 17.9 nm and that of PS (100) micelles
with no PEG was 127.3 ± 23.3 nm. Transmission electron
microscopy (TEM) was performed to further characterize
the morphology of the PS (50) micelles. Negatively stained
PS (50) micelles appear as small unilamellar vesicular
structures with a size of approximately 50 nm with about
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Figure S2). With increasing PS, the surface charge of PS-
QD micelles increased from −14.5 ± 7.5 mV for PS (50)
micelles, −16.4 ± 6.9 mV for PS (60) micelles, to −32.5 ±
7.8 mV for PS (100) micelles (Figure 1). Another im-
portant consideration when preparing nanoparticles for
in vivo use is their colloidal stability in serum. The aggre-
gation property of the micelles was studied by monitoring
the change in their hydrodynamic diameter after 24 h of
incubation with 10% (v/v) serum-containing media. The
stability of PS-QD micelles decreases with increasing con-
centration of PS, PS (40) > PS (50) > PS (60) > PS (100)
(Additional file 1: Figure S4). The results suggest that an
amount of 50 to 60 mol% PEG for PS-PL-PEG micelles
with 6- to 8-nm hydrophobic QD core is optimal for gen-
erating uniformly small micelles, for further evaluation. InFigure 2 Flow cytometry histogram profiles of untreated control cells
(A) Varying PS-QD micelles: PS (0, 40, 50, 60, and 100) incubated with macr
flourescence intensity values of the histograms, (B) histogram profile of ma
(C) histogram profile of macrophage cells treated with PS (50-2) QD micellvitro cytotoxicity of various PS-QD micelle preparations
was also evaluated in J774A.1 cells. Up to 50 nM, all prep-
arations of PS-QD micelles were found to be non-toxic to
macrophages when incubated for 24 h, as assessed by
MTTcell viability assay (Additional file 1: Figure S7).
To demonstrate the ability of PS-QD micelles to tar-
get and subsequently phagocytosed by macrophages,
J774A.1 cells were incubated with PS-QD micelles con-
taining variable amount of PS (40, 50, 60, and 100 mol%
PS). The extent of micelle uptake by macrophages was
quantified by fluorescence-activated cell sorting (FACS).
It was hypothesized that increasing PS mol% and de-
creasing PL-PEG packing density on micelles would de-
termine the rate of internalization of PS-QD micelles by
macrophages. The principles of protein interactions and
PEGylated surfaces are well known and states that PEG(gray colored) versus PS-QD micelle-treated macrophage cells.
ophages for 4 h and analysed by flow cytometry, inset shows mean
crophage cells treated with PS (50-1) and PS (50-2) micelle formulation,
e showing PS-dependent macrophage uptake.
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densities [20]. As expected, the uptake of PS micelles
by macrophages increased with increasing PS mol%
(Figure 2, Additional file 1: Figure S5-S6) with the excep-
tion of PS (50) micelles. PS micelles with low PEG and
high PS content: (i) PS (100) micelle treated macro-
phages showed nearly fourfold increase in cell uptake
compared to PS (0) micelles and the cell count (his-
togram peak height) was similar to (histogram peak
height) control untreated cells, demonstrating that all
cells take up PS (100) micelles (mean fluorescence inten-
sity (MFI) 23.4 versus 5.6), even though they form 2-μm
particles when incubated in culture media, this result
indicates that micron-sized particles are uptaken by
macrophages. (ii) PS (60) micelles showed a threefold in-
crease in cell uptake (MFI 17 versus 5.6) but the cell
count (histogram peak height) was half that of PS (0)
treated macrophages indicating that not all the micelles
are internalized by macrophages resulting in lower num-
ber of cells containing PS-QD micelles (Figure 2A). For
PS micelles with high PEG and low PS content, (iii) the
uptake of PS (0) micelle by macrophages was not signifi-
cant compared to untreated control (MFI 5.6 versus 3.5),
(iv) PS (40) with a mean particle size of approximately
80 to 100 nm, showed only a onefold increase in cell up-
take compared to PS (0) micelles (MFI 7.4 versus 5.6),Figure 3 Schematic representation of PS-QD micelles and evaluation
macrophages was tested as a function of micelle size and PS coverage. Theand (v) PS (50) micelles (approximately 40 nm) showed
no cell uptake, almost no change in QD peak intensity
and were similar to control untreated cells (MFI 3.3 ver-
sus 3.5; Figure 2A). The results demonstrate that high
PEG density on micelles results in closely packed PEG
surface that resembles a brush type conformation, result-
ing in blocking PS recognition by macrophages [20,21].
Consistent with prior reports that demonstrated PEGyla-
tion on the surface of QD could substantially block the
uptake of 15- to 30-nm particles by macrophages [19],
the PS (50) micelles with 50 mol% PEG appeared to
evade uptake by J774A.1 cells as assessed by flow cytom-
etry (Figure 2). Fluorescent microscopy also confirmed
the lack of uptake of PS (50) micelles by J774A.1 cells
(Figure 3). It has been reported that PEG density affects
macrophage uptake more for smaller sized nanoparticles
compared to larger nanoparticles [19] and the results are
in agreement. We therefore hypothesized that by in-
creasing the micelle size, a fine balance between colloidal
stability and macrophage targeting can be achieved.
Next, the PEG packing density of PS (50) micelles was
controlled by tuning the homogenization speed of the
micro-emulsion that resulted in the preparation of mi-
celles of two different sizes of approximately 40-nm PS
(50-1) and approximately 100-nm PS (50-2) micelles.
When tested for macrophage-specific targeting, it wasof their targeting efficacy. Uptake of PS-QD micelles by J774A.1
uptake was highest for PS (100) and minimal for PS (50).
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40 nm were not uptaken by macrophages (incubated at 25
pM) and at different micelle concentrations (Additional
file 1: Figure S6), while PS (50-2) micelles with a size of
approximately 100 nm in size are avidly uptaken by mac-
rophages (MFI 15.1 versus 5.6) (Figure 2B). Further, the
possibility that the uptake of larger-sized PS (50-2) mi-
celles by macrophages were indeed correlated to the sur-
face coverage of PS in the micelles and independent of
surface negative charge was also investigated. For this
purpose, the amount of PS in the PS (50-2) micelles was
varied by substituting PS with a negatively charged lipid:
1,2-dipalmitoyl-sn-glycero-3-phospho-(glycerol) (DPPG)
at two PS-DPPG molar ratios (40:10 and 30:20) but kee-
ping the overall molar ratio constant at 50 mol%). As
shown in Figure 2C, PS-PG (40:10) micelles containing
more PS than PS-PG (30:20) micelles were taken up to a
higher degree by macrophages, suggesting macrophage
uptake of micelles was dependent on the PS content in
micelles and independent of the surface charge. The above
results show that PEG coverage and size can be fine-tuned
to influence the surface exposure of PS and thus permit or
block the ligand receptor recognition and cell uptake.
Conclusions
In conclusion, a size-dependent uptake of approximately
100-nm PS-QD micelles that resemble dead/apoptotic
cells and recognized as ‘self ’ are detected and uptaken by
macrophage-like cells, whereas PS-QD micelles that are
intermediate in size (approximately 40 nm) and recog-
nized as ‘non-self ’ are not uptaken by macrophage-like
cells. The importance of this study based on the size and
phospholipid coating of equal molar ratio of PS and PL-
PEG for nanoparticles can be further extended to tar-
geted delivery of inorganic particles for imaging or drug
delivery applications.
Additional file
Additional file 1: Figure S1-S7. Supporting Information. In vitro uptake
of apoptotic body mimicking phosphatidylserine-quantum dot micelles
by monocytic cell line.
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